8 research outputs found

    Combination of pharmacotherapy and lidocaine analgesic block of the peripheral trigeminal branches for trigeminal neuralgia: a pilot study

    Get PDF
    Classical trigeminal neuralgia (CTN) is treated predominantly by pharmacotherapy but side effects and unsuccessful occurs. The current study was carried out to evaluate the therapeutic effect of combination of pharmacotherapy and lidocaine block. Thirteen patients with CTN managed with pharmacotherapy were recruited and assigned either to no additional treatment (Group I) or to additional analgesic block (Group II). The primary endpoint was the reduction in the frequency of pain episodes in a month assessed at 30 and 90 days. Comparisons of measurements of pain, general health and depression scales were secondary endpoints. The results from the follow-up visits at 30 and 90 days showed the Group II to have larger reduction in the frequency of pain and exhibited a bigger improvement in the scores of the pain, general health and depression scales. The results from this preliminary study suggest a clinical benefit of the combination of pharmacotherapy and lidocaine block

    Uncontrolled headache induced by oxcarbazepine

    Get PDF
    Headache induced by acute exposure to a specific drug constitutes an idiosyncratic side effect. Metabolic imbalance appears as the leading aetiology, among several other hypotheses. Either primary headaches show a higher susceptibility to this idiosyncratic reaction or a drug-induced primary headache evolves in intensity and duration, becoming uncontrolled until the complete discontinuation of the drug in consideration. The goal of this study is to describe three patients diagnosed with migraine and epilepsy (both under control) who evolved into status migrainosus after the introduction of oxcarbazepine (OXC), as part of a switch off from carbamazepine (CBZ). Twenty-four to seventy-two hours following the switch, all patients developed intractable headache, despite the use of different symptomatic drugs. Complete recovery of the headache symptoms occurred only after OXC was discontinued. We discuss the potential mechanisms associated to OXC and status migrainosus, drug-induced headaches and uncontrolled headaches

    Massaging over the greater occipital nerve reduces the intensity of migraine attacks: evidence for inhibitory trigemino-cervical convergence mechanisms Massagem sobre o nervo occipital maior reduz a intensidade dos ataques de migrĂąnea: evidĂȘncia de mecanismos de convergĂȘncia inibitĂłrios trigemino-cervical

    No full text
    Activation of the trigemino-cervical system constitutes one of the first steps in the genesis of migraine. The objective of this study was to confirm the presence of trigemino-cervical convergence mechanisms and to establish whether such mechanisms may also be of inhibitory origin. We describe a case of a 39-years-old woman suffering from episodic migraine who showed a significant improvement in her frontal headache during migraine attacks if the greater occipital nerve territory was massaged after the appearance of static mechanical allodynia (cortical sensitization). We review trigemino-cervical convergence and diffuse nociceptive inhibitory control (DNIC) mechanisms and suggest that the convergence mechanisms are not only excitatory but also inhibitory.Ativação do sistema trigemino-cervical constitui um dos primeiros passos na gĂȘnese da crise de migrĂąnea. O objetivo do estudo foi descrever um caso clĂ­nico que sugere a existĂȘncia de mecanismos de convergĂȘncia trigemino-cervical (CTC) e que esses possam ser do tipo inibitĂłrios. NĂłs descrevemos o caso de mulher de 39 anos com migrĂąnea episĂłdica que mostrou significante melhora em sua cefalĂ©ia frontal durante suas crises quando realizava massagem sobre o territĂłrio do nervo occipital maior ipsilateral a dor. A melhora clĂ­nica sĂł ocorria quando a paciente apresentava alodinia mecĂąnica estĂĄtica (sensibilização cortical). Neste estudo nĂłs revisamos os conceitos de CTC e de mecanismos de controle inibitĂłrio nociceptivo difuso (MCIN), sugerindo que este Ășltimo Ă© um elemento comprobatĂłrio da presença de CTC do tipo inibitĂłrio durante as crises de migrĂąnea
    corecore